Academic Journals Database
Disseminating quality controlled scientific knowledge

Pharmaceutical equivalence of gabapentin tablets with various extragranular binders Pharmaceutical equivalence of gabapentin tablets with various extragranular binders

ADD TO MY LIST
 
Author(s): Swati C. Jagdale | Bhanudas Kuchekar | Jibanananda satapathy | Aniruddha Chabukswar

Journal: Revista de Ciências Farmacêuticas Básica e Aplicada
ISSN 1808-4532

Volume: 31;
Issue: 1;
Start page: 25;
Date: 2010;
Original page

Keywords: Dissolution | Gabapentin | Tablet | Binder | Pharmaceutical equivalence | Gabapentina | Equivalência farmacêutica | Comprimidos.

ABSTRACT
Gabapentin is a high-dose drug widely used as an oral anti-epilepticagent. Due to high crystalline and has poor compaction properties it is difficult to form tablets by direct compression. The aim of this study was to develop gabapentin tablets, pharmaceutically equivalent to the reference product Neurontin (marketed in USA). Gabapentin 800mg tablets were produced by wet granulation by keeping intragranular binder as well as its concentration constant and by changing with various extragranular binders with its concentration (A = PVPK 30, B = HPMC 15 cps, C = Kollidon VA 64, D =Klucel EXF).The tablet having no weight, thickness and hardness variation and having appropriate, friability as well as disintegration profile were coated with a 3% film coating solution .Seven formulations F1 (A in lower concentration) F2 (A in higher concentration), F3 (B in lower concentration) and F4 (B in higher concentration), F5 (C in lower concentration), F6 (C in higher concentration), F7 (D in lower concentration) were formulated. Among them F6 demonstrated adequate hardness, friability, disintegration, uniformity of content, and total drug dissolution after 45minutes. The dissimilarity factor (f1) is 5.93 and the similarity factor (f2) is 67.85. So F6 was found to be equivalent to Neurontin. Gabapentin is widely used as an oral anti-epileptic agent. However, owing to its high crystallinity and poor compaction properties, it is difficult to form tablets of this drug by direct compression. The aim of this study was to develop gabapentin tablets, pharmaceutically equivalent to the brand-name pioneer product Neurontin® (marketed in USA). Gabapentin 800mg tablets were produced by wet granulation with a constant concentration of intragranular binder and a varying concentration of extragranular binders (A = polyvinylpyrrolidone K30, B = hydroxypropylmethylcellulose 15 cps, C = Kollidon VA64, D =Klucel EXF). The tablets that did not vary in weight, thickness or hardness and had appropriate friability and disintegration profiles were coated with a 3% film-coating solution. Seven formulations F1 (A 3%), F2 (A 6%), F3 (B 3%), F4 (B 6%), F5 (C 3%), F6 (C 3%) and F7 (D 3%) were prepared. Among these, F6 exhibited adequate hardness, friability, disintegration, uniformity of content and total drug dissolution after 45minutes. Comparing the F6 dissolution profile with that of the brand-name tablets, the difference factor (f1) was 5.93 and the similarity factor (f2) 67.85. Hence, formulation F6 was found to be equivalent to Neurontin®. Keywords: Dissolution. Gabapentin. Tablet. Binder. Pharmaceutical equivalence.
Save time & money - Smart Internet Solutions      Why do you need a reservation system?